INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT
|
|
- Scarlett Young
- 6 years ago
- Views:
Transcription
1 INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT PLEASE INFORM THE PALLIATIVE CARE TEAM ON COMMENCEMENT OF THIS ICP (EXT 8958) ICP Start Date Patient s Name. Ward. Consultant.. Named Specialist Nurse Date of Birth.. Hospital No.... Named Nurse..... Tel No... This Integrated Care Pathway is a guide to treatment. Practitioners are free to exercise their own professional judgement. Any alteration to the practice identified within this ICP must be recorded as a variance on the variance recording sheet at the back of the pathway Instructions for use: All goals are in heavy typeface. Prompts to support the goals are in normal type. During use, if a goal is not achieved (i.e. variance) please record reason/action on the variance recording sheet. All staff documenting in the care pathway must first complete the signature page (pg 2) of the ICP. Please initial responses to all questions/goals. This pathway can be discontinued if patient s condition stipulates (Date...) CRITERIA FOR USING THIS ICP Please start the ICP when the multi-professional team have AGREED that the patient is DYING and fulfils any two of the following criteria: Please tick: Bed bound Comatose or Semi Comatose Only able to take sips of fluids No longer able to take tablets Please consider NFR status. Patient should have underlying, life threatening and incurable illness. Reversible measures for current deterioration in condition should be considered. Reference: Ellershaw J & Wilkinson S Eds. Care for the Dying: A Pathway to Excellence. Oxford University Press: Oxford, 2003 Ref: J414 1 CM4436
2 All personnel completing the care pathway please sign & initial below (each member of staff needs to do this once only) Name (print) Full signature Initials Professional title Date 2
3 Name:... Unit no: Date/Time commenced:... Section 1 Diagnosis & Demographics Initial assessment Goals 1 to 3 to be completed by Doctor PRIMARY DIAGNOSIS: SECONDARY DIAGNOSIS: Physical condition Comfort measures Unable to swallow Yes No Aware Yes No Nausea Yes No Conscious Yes No Vomiting Yes No UTI problems Yes No Constipated Yes No Catheterised Yes No Confused Yes No Respiratory tract secretions Yes No Agitation Yes No Dyspnoea Yes No Restless Yes No Pain Yes No Distressed Yes No Other (e.g. oedema, itch) Yes No Goal 1: Current medication assessed and non essentials discontinued Yes No Appropriate oral drugs converted to subcutaneous route and syringe driver commenced if appropriate (see attached algorithms) Inappropriate medication discontinued. Goal 2: PRN subcutaneous medication written up from list below as per protocol (See algorithms at back of LCP for guidance) Pain Analgesia Yes No Agitation Sedative Yes No Respiratory tract secretions Anticholinergic Yes No Nausea & vomiting Anti-emetic Yes No Dyspnoea Anxiolytic / Muscle relaxant Yes No Goal 3: Discontinue inappropriate interventions Blood test Yes No N/A Antibiotics Yes No N/A I.V. fluids/medications Yes No N/A Not for cardiopulmonary resuscitation recorded Yes No (Please record below & complete Trust Yellow Resusitation Status Form)... Deactivate cardiac defibrillator (ICD) Yes No N/A Contact patient s Cardiologist Refer to local policy and procedures Doctor s signature:... Date:... Goal 3a: Decisions to discontinue inappropriate nursing interventions taken Yes No Routine turning regime reposition for comfort only consider pressure relieving mattress & appropriate assessments re skin integrity. Discontinue EWS If BM monitoring in place reduce frequency as appropriate e.g. once daily Goal 3b: Syringe driver set up within 4 hours of doctor s order Yes No N/A Nurse signature:... Date:... Time:... 3
4 Section 1 Initial assessment - Continued Psychological/ insight Goal 4: Ability to communicate in English assessed as adequate a) Patient Yes No Comatose b) Family/other Yes No Goal 5: Insight into condition assessed Aware of diagnosis a) Patient Yes No Comatose b) Family/other Yes No Recognition of dying c) Patient Yes No Comatose d) Family/other Yes No Religious/ Spiritual support Goal 6: Religious/spiritual needs assessed a) with Patient Yes No Comatose b) with Family/other Yes No Patient/other may be anxious for self/others Consider specific cultural needs Consider support of Chaplaincy Team Religious Tradition identified, if yes specify: Yes No N/A.. Support of Chaplaincy Team offered Yes No In-house support Tel/bleep no: Name: Date/time: External support Tel/bleep no: Name: Date/time: Comments (Special needs now, at time of impending death, at death & after death identified) Communication with family/other Goal 7: Identify how family/other are to be informed of patient s impending death Yes No At any time Not at night-time Staying overnight at Hospital First contact name:... Relationship to patient:... Tel no:... Second contact:... Tel no:... Goal 8: Family/other given hospital information:- Yes No Facilities leaflet is available to address: Car parking; Accommodation; Beverage facilities; Payphones; Washrooms & toilet facilities on the ward; Visiting times; Any other relevant information. C o m m u n i c a t i o n w i t h p r i m a r y h e a l t h c a r e t e a m Goal 9: G.P. Practice is aware of patient s condition G.P. Practice to be contacted if unaware patient is dying, message can be left with the receptionist Yes No Summary Goal 10: Plan of care explained & discussed with: a) Patient Yes No Comatose b) Family/other Yes No Goal 11: Family/other express understanding of planned care Yes No Family/other aware of the aims of planned care, ie; focusing on comfort, dignity and good symptom control If you have charted No against any goal so far, please complete the variance sheet. Health Professional signature:... Title:... Date:... 4
5 Codes (please enter in columns) A= Achieved V=Variance (not a signature) Section 2 Patient problem/focus 04:00 08:00 12:00 16:00 20:00 24:00 Ongoing assessment Pain Goal A: Patient is pain free Verbalised by patient if conscious Pain free on movement Appears peaceful Consider need for positional change Agitation Goal B: Patient is not agitated Patient does not display signs of delirium, terminal anguish, restlessness (thrashing, plucking, twitching) Exclude retention of urine as cause Consider need for positional change Respiratory tract secretions Goal C: Excessive secretions are not a problem Medication to be given as soon as symptoms arise Consider need for positional change Symptom discussed with family/other Nausea & vomiting Goal D: Patient does not feel nauseous or vomit Patient verbalises if conscious Dyspnoea Goa E: Breathlessness is not distressing for patient Patient verbalises if conscious. Consider need for positional change. Other symptoms (e.g. oedema, itch)... Treatment/procedures Mouth care Goal F: Mouth is moist and clean Mouth care assessment at least 4 hourly Frequency of mouth care depends on individual need Family/other involved in care given Micturition difficulties Goal G: Patient is comfortable Urinary catheter if in retention Urinary catheter or pads, if general weakness creates incontinence Medication (If medication not required please record as N/A) Goal: All medication is given safely & accurately If syringe driver in progress check at least 4 hourly and complete syringe driver monitoring chart Signature Repeat this page 24 hrly. Spare copies on Ward If you have charted V against any goal so far, please complete variance sheet on the back page Name:... Unit no:... Date:... 5
6 Codes (please enter in columns) A= Achieved V=Variance 08:00 20:00 Mobility/Pressure area care Bowel care Psychological/ Insight support Goal H: Patient is comfortable and in a safe environment Clinical assessment of: Skin integrity Need for positional change Need for special mattress Personal hygiene, bed bath, eye care needs Goal I: Patient is not agitated or distressed due to constipation or diarrhoea Patient Goal J: Patient becomes aware of the situation as appropriate Patient is informed of procedures Touch, verbal communication is continued Family/other Goal K: Family/other are prepared for the patient s imminent death with the aim of achieving peace of mind and acceptance Check understanding of nominated family/others / younger adults / children Check understanding of other family/others not present at initial assessment Ensure recognition that patient is dying & of the measures taken to maintain comfort Chaplaincy Team support offered Religious/ Spiritual support Care of the family /others Goal L: Appropriate religious/spiritual support has been given Patient/other may be anxious for self/others Support of Chaplaincy Team may be helpful Consider cultural needs Goal M: T h e needs of those attending the patient are accommodated Consider health needs & social support. Ensure awareness of ward facilities Health Professional Signature Early:... Late:..... Night:... Multidisciplinary progress notes Name:... Unit no:... Date:... 6
7 Codes (please enter in columns) A= Achieved V=Variance (not a signature) Section 2 Patient problem/focus 04:00 08:00 12:00 16:00 20:00 24:00 Ongoing assessment Pain Goal A: Patient is pain free Verbalised by patient if conscious Pain free on movement Appears peaceful Consider need for positional change Agitation Goal B: Patient is not agitated Patient does not display signs of delirium, terminal anguish, restlessness (thrashing, plucking, twitching) Exclude retention of urine as cause Consider need for positional change Respiratory tract secretions Goal C: Excessive secretions are not a problem Medication to be given as soon as symptoms arise Consider need for positional change Symptom discussed with family/other Nausea & vomiting Goal D: Patient does not feel nauseous or vomit Patient verbalises if conscious Dyspnoea Goal E: Breathlessness is not distressing for patient Patient verbalises if conscious. Consider need for positional change. Other symptoms (e.g. oedema, itch)... Treatment/procedures Mouth care Goal F: Mouth is moist and clean Mouth care assessment at least 4 hourly Frequency of mouth care depends on individual need Family/other involved in care given Micturition difficulties Goal G: Patient is comfortable Urinary catheter if in retention Urinary catheter or pads, if general weakness creates incontinence Medication (If medication not required please record as N/A) Goal H: All medication is given safely & accurately If syringe driver in progress check at least 4 hourly and complete monitoring sheet Signature Repeat this page 24 hrly. Spare copies on Ward If you have charted V against any goal so far, please complete variance sheet on the back page Name:... Unit no:... Date:... 7
8 Codes (please enter in columns) A= Achieved V=Variance 08:00 20:00 Mobility/Pressure area care Bowel care Psychological/ Insight support Goal I: Patient is comfortable and in a safe environment Clinical assessment of: Skin integrity Need for positional change Need for special mattress Personal hygiene, bed bath, eye care needs Goal J: Patient is not agitated or distressed due to constipation or dia r r h o e a Patient Goal K: Patient becomes aware of the situation as appropriate Patient is informed of procedures Touch, verbal communication is continued Family/other Goal L: Family/other are prepared for the patient s imminent death with the aim of achieving peace of mind and acceptance Check understanding of nominated family/others / younger adults / children Check understanding of other family/others not present at initial assessment Ensure recognition that patient is dying & of the measures taken to maintain comfort Chaplaincy Team support offered Religious/ Spiritual support Care of the family /others Goal M: Appropriate religious/spiritual support has been given Patient/other may be anxious for self/others Support of Chaplaincy Team may be helpful Consider cultural needs Goal N: The needs of those attending the patient are accommodated Consider health needs & social support. Ensure awareness of ward facilities Health Professional Signature Early:... Late:..... Night:... Multidisciplinary progress notes Name:... Unit no:... Date:... 8
9 Codes (please enter in columns) A= Achieved V=Variance (not a signature) Section 2 Patient problem/focus 04:00 08:00 12:00 16:00 20:00 24:00 Ongoing assessment Pain Goal A: Patient is pain free Verbalised by patient if conscious Pain free on movement Appears peaceful Consider need for positional change Agitation Goal B: Patient is not agitated Patient does not display signs of delirium, terminal anguish, restlessness (thrashing, plucking, twitching) Exclude retention of urine as cause Consider need for positional change Respiratory tract secretions Goal C: Excessive secretions are not a problem Medication to be given as soon as symptoms arise Consider need for positional change Symptom discussed with family/other Nausea & vomiting Goal D: Patient does not feel nauseous or vomit Patient verbalises if conscious Dyspnoea Goal E: Breathlessness is not distressing for patient Patient verbalises if conscious. Consider need for positional change. Other symptoms (e.g. oedema, itch)... Treatment/procedures Mouth care Goal F: Mouth is moist and clean Mouth care assessment at least 4 hourly Frequency of mouth care depends on individual need Family/other involved in care given Micturition difficulties Goal G: Patient is comfortable Urinary catheter if in retention Urinary catheter or pads, if general weakness creates incontinence Medication (If medication not required please record as N/A) Goal H: All medication is given safely & accurately If syringe driver in progress check at least 4 and complete monitoring sheet Signature Repeat this page 24 hrly. Spare copies on Ward If you have charted V against any goal so far, please complete variance sheet on the back page 9
10 Name:... Unit no:... Date:... Codes (please enter in columns) A= Achieved V=Variance 08:00 20:00 Mobility/Pressure area care Bowel care Psychological/ Insight support Goal I: Patient is comfortable and in a safe environment Clinical assessment of: Skin integrity Need for positional change Need for special mattress Personal hygiene, bed bath, eye care needs Goal J: Patient is not agitated or distressed due to constipation or diarrhoea Patient Goal K: Patient becomes aware of the situation as appropriate Patient is informed of procedures Touch, verbal communication is continued Family/other Goal L: Family/other are prepared for the patient s imminent death with the aim of achieving peace of mind and acceptance Check understanding of nominated family/others / younger adults / children Check understanding of other family/others not present at initial assessment Ensure recognition that patient is dying & of the measures taken to maintain comfort Chaplaincy Team support offered Religious/ Spiritual support Care of the family /others Goal M: Appropriate religious/spiritual support has been given Patient/other may be anxious for self/others Support of Chaplaincy Team may be helpful Consider cultural needs Goal N: The needs of those attending the patient are accommodated Consider health needs & social support. Ensure awareness of ward facilities Health Professional Signature Early:... Late:..... Night:... Multidisciplinary progress notes 10
11 SECTION 3 Care after death Patients Surname First name Hosp No: Date of death: Time of death: Persons present: Verification of Death by (please print) Time: Pupils fixed and dilated Yes Breathing absent Yes Pulse absent Yes Heart sounds absent Yes Signature Care after death Goal 12: Healthcare Professionals Contacted: GP Practice telephoned re: patient s death Yes No Palliative Care Team informed (X8958) Yes No Chaplaincy Team if required Yes No Goal 13: Last offices guidleines followed according to hospital policy Carry out specific religious / spiritual / cultural needs - requests Goal 14: Procedure following death discussed or carried out Check for the following: Explain mortuary viewing as appropriate Post mortem discussed as appropriate. Input patients death on hospital computer Yes No Yes No Goal 15: Family/other given information on hospital procedures Yes No Information given to family/other Relatives/other informed to ring Bereavement Office to make an appointment to collect death certificate Goal 16:Hospital policy followed for patient s valuables & belongings Belongings and valuables are signed for by identified person Property packed for collection. Valuables listed and stored safely Goal 17: Necessary documentation & advice is given to the appropriate person Hospitals When someone dies booklet given to family/other Goal 18:Bereavement leaflet given Information leaflet on grieving given to family/other Yes No Yes No Yes No If you have charted No against any goal so far, please complete the variance sheet at the back of the pathway before signing below Health Professional signature:... Date:... 11
12 Name:... Unit no:... NHS no:... Variance analysis What Variance occurred & why? Action Taken Outcome Goal:- Goal:- Goal:- Goal:- Goal:- 12
13 Name:... Unit no:... NHS no:... Variance analysis What Variance occurred & why? Action Taken Outcome Goal:- Goal:- Goal:- Goal:- Goal:- 13
14 THE PATIENT IN PAIN (and unable to swallow) HAS NOT PREVIOUSLY TAKEN OPIOIDS REGULAR S/C MORPHINE Administer 4 hourly morphine 2.5-5mgs s/c and prn doses until syringe driver commenced (i.e. when response to PRN assessed) IS ALREADY T AKING REGULAR ORAL MORPHINE AND IS NOT WEARING A FENTANYL TRANSDERMAL PATCH (If taking other opioids e.g. oxycodone, hydromorphone, please contact Specialist Palliative Care Team)* REGULAR S/C MORPHINE To calculate the s/c morphine dose, divide the prn oral morphine dose by 2. Administer 4 hourly s/c morphine and prn doses as indicated until s yr inge driver commenced. IS WEARING A FENTANYL TRANSDERMAL PATCH CONTINUE FENTANYL PATCH. Administer s/c morphine prn as indicated below until continuous morphine commenced CONTINUOUS S/C MORPHINE Use Table One in Appendix One. The CSCI dose increases the analgesia the patient is receiving by 33% (equivalent to two PRN doses). CONTINUOUS S/C MORPHINE (CSCI) Morphine 10-20mg via syringe driver over 24 hours or guided by morphine requirement prior to commencement of continuous subcutaneous infusion CONTINUOUS S/C MORPHINE To calculate the equivalent dose of morphine s/c over 24 hours via syringe driver, divide the total 24 hour dose of oral morphine by 2. PRN S/C MORPHINE To calculate the new prn dose of morphine divide the 24 hour dose of morphine in the syringe driver by 6. Example: patient receiving 60mg of morphine s/c over 24 hours, the prn dose of morphine should be 10mg s/c PRN. PRN S/C MORPHINE** Use Table One in Appendix One. The PRN dose is calculated by dividing the amount of morphine in the syringe driver by 6 (a) and adding this to the breakthrough dose for the fentanyl patch (b). Example: if the patient is wearing a 100 microgram/hour patch and has 60mg morphine s/c over 24 hours, the prn dose of morphine should be 40mg a = 10 b = 30 Table Two in Appendix One is used to calculate the breakthrough dose for fentanyl patches and for adjusting subsequent doses (See below) TO CALCULATE THE SUBSEQUENT DOSES OF MORPHINE OVER 24 HOURS Add the dose of morphine in the syringe driver to any morphine given on a prn basis over the previous 24 hours. Recalculate the prn dose as a sixth of the new 24 hour dose. Example: if the patient has 60mg of morphine s/c over 24 hours and has received 3 doses of 10mg s/c, the required dose of morphine will be 90mg s/c over the next 24 hours and 15mg morphine s/c prn. If a fentanyl patch is also being worn then the prn morphine dose will be recalculated as in the above box** IF SYMPTOMS PERSIST REQUEST MEDICAL REVIEW AND CONTACT SPECIALIST PALLIATIVE CARE TEAM* Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
15 THE PAIN CONTROLLED PATIENT (and unable to swallow) HAS NOT PREVIOUSLY TAKEN OPIOIDS IS ALREADY T AKING REGULAR ORAL MORPHINE AND IS NOT WEARING A FENTANYL T R AN SDERMAL PATCH (if taking other opioids e.g. oxycodone, hydromorphone, please contact your Specialist Palliative CareTeam)* IS WEARING A FENTANYL TRANSDERMAL PATCH REGULAR S/C MORPHINE To calculate the s/c morphine dose, divide the prn oral morphine dose by 2. Administer 4 hourly s/c morphine until syringe driver commenced. CONTINUE FENTANYL PATCH PRESCRIBE PRN S/C MORPHINE Morphine 2.5-5mg s/c prn CONTINUOUS S/C MORPHINE To calculate the equivalent dose of morphine s/c over 24 hours via syringe driver, divide the total 24 hour dose of oral morphine by 2. Example: patient on 90mg morphine sulphate m/r bd = 180mg morphine sulphate m/r over 24 hours. Divided by 2 = 90mg morphine via syringe driver over 24 hours PRESCRIBE PRN S/C MORPHINE Fentanyl 25 = 7.5mg s/c morphine prn Fentanyl 50 = 15mg s/c morphine prn Fentanyl 75 = 20 25mg s/c morphine prn Fentanyl 100 = 30mg s/c morphine prn (See Table Two in Appendix One) IF PRN MORPHINE REQUIRED THEN MOVE TO APPROPRIATE PART OF THE PATIENT IN PAIN ALGORITHM Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
16 ARE RESPIRATORY TRACT SECRETIONS PRESENT? YES NO Give s/c bolus injection of glycopyrronium 200mcg (0.2mg) and repeat 6 hourly until syringe driver commenced PRESCRIBE PRN MEDICATION Glycopyrronium 200mcg (0.2mg) s/c 6 hourly PRN COMMENCE A CONTINUOUS S/C INFUSION AT EARLIEST OPPORTUNITY Glycopyrronium 600mcg (0.6mg) over 24 hours IF RESPIRATORY TRACT SECRETIONS PERSIST OVER THE NEXT 24 HOURS INCREASE DOSE TO: NOTE The BNF lists this antimuscarinic drug as glycopyrronium bromide. Ampoules are labelled as glycopyrrolate and boxes are labelled as both glycopyrronium bromide and glycopyrrolate Glycopyrronium 1.2mg over 24 hours IF SYMPTOMS PERSIST REQUEST MEDICAL REVIEW AND CONTACT SPECIALIST PALLIAT IVE CARE TEAM* Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
17 IS THE PATIENT EXPERIENCING TERMINAL RESTLESSNESS & AGITATION? YES NO Midazolam 2.5 5mg s/c prn until syringe driver commenced If 2.5mg ineffective after 30minutes, give 5mgs. If second dose ineffective after a further 30 minutes (total 1 hour) seek Medical Review and contact Specialist Palliative Care Team (who may advise that the prn dose is increased ) * PRN medication Midazolam 2.5 5mg s/c prn COMMENCE A CONTINUOUS S/C INFUSION (CSCI) With dose guided by prn requirements of midazolam prior to starting syringe driver If requiring 2.5 mg prn give 15mg via CSCI over 24 hours If requiring 5mg prn give 30mg via CSCI over 24 hours If requiring 10 mg prn give 60mg via CSCI over 24 hours To calculate the subsequent doses of midazolam Add the dose of midazolam in the s yr inge driver to any midazolam given on a prn basis over 24 hours Increase the prn dose of midazolam accordingly IF SYMPTOMS PERSIST REQUEST MEDICAL REVIEW AND CONTACT SPECIALIST PALLIATIVE CARE TEAM* Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
18 THE PATIENT IS BREATHLESS GENERAL MEASURES Explanation Companionship Fan/open window Oxygen Reposition IS THERE A REVERSIBLE CAUSE THAT C AN BE TREATED WITHOUT INVASIVE/AGGRESSIVE INTERVENTION? YES Treat the cause e.g. nebulised bronchodilators for bronchospasm, diuretics for distressing dyspnoea due to heart failure NO Symptomatic treatment to relieve distress First line treatment - opioids: If no previous opioid commence morphine 2.5-5mg s/c prn If previous opioid, increase dose by 30% and if agitated add midazolam 2.5 5mgs s/c prn. After 2 or more prn doses assess need for syringe driver / seek medical advice and contact Specialist Palliative Care Team* If still symptomatic, to relieve distress IF SYMPTOMS PERSIST REQUEST MEDICAL REVIEW AND CONTACT SPECIALIST PALLIATIVE CARE TEAM* Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
19 IS THE PATIENT EXPERIENCING NAUSEA AND VOMITING? YES NO IS THE PATIENT EXPERIENCING BOWEL OBSTRUCTION? PRN MEDICAT I ON Levomepromazine (methotrimeprazine) mg s/c 4 hourly PRN NO YES WAS THE SYMPTOM PREVIOUSLY CONTROLLED ON A PROKINETIC ANTI-EMETIC? i.e. METOCLOPRAMIDE OR DOMPERIDONE YES NO CONTACT THE MEDICAL STAFF/ SPECIALIST PALLIATIVE CARE TEAM* Give s/c bolus injection of metoclopramide 10mg Commence a continuous s/c infusion metoclopramide mg over 24 hours Give s/c bolus injection of levomepromazine 6.25mg (methotrimeprazine) Commence a continuous s/c infusion levomepromazine (methotrimeprazine) mg over 24 hours IF SYMPTOMS PERSIST REQUEST MEDICAL REVIEW AND CONTACT SPECIALIST PALLIAT IVE CARE TEAM* Specialist Palliative Care Team Urgent Pager (9am 5pm weekdays) Although the use of drugs outside their licence is recognised practice in palliative care, the prescribing doctor takes personal responsibility for the prescription. Information for this algorithm is taken from the CMMC Pain & Symptom Control Guidelines Algorithm amended August 2008.
20 Appendix One: Tables for patients wearing fentanyl patches and unable to swallow Use Table One to find the dose of morphine to put in the s/c syringe driver over 24 hours in addition to the fentanyl patch. Prescribe appropriate PRN dose for breakthrough. For patients on other doses e.g. fentanyl 37 micrograms/hr patch add together the doses for the two patches (12 micrograms/hr and 25 micrograms/hr) 10mg amd 15mg = 25mg for CSCI and 5mg and 10mg = 15mg for PRN dose. Table One: Patient in pain wearing a fentanyl patch and now requiring continuous subcutaneous infusion (CSCI) morphine Fentanyl patch dose (micrograms/hr) Morphine 24hr CSCI Morphine PRN s/c mg 5mg 25 15mg 10mg 50 30mg 20mg 75 45mg 30mg mg 40mg mg 50mg mg 60mg mg 70mg (2 sites) mg 80mg (2 sites) mg 90mg (2 sites) mg 100mg (2 sites) mg 110mg (2 sites) mg 120mg (2 sites) Use Table Two to prescribe the PRN dose of morphine for patients on fentanyl patches and to calculate PRN dose for patients on a fentanyl patch requiring CSCI morphine Table Two: Pain controlled patient wearing a fentanyl patch who requires `breakthrough with parenteral (subcutaneous) morphine Fentanyl patch dose (micrograms/hr) Morphine PRN s/c mg mg 50 15mg mg mg mg mg mg mg mg (2 sites) mg (2 sites) mg (2 sites) mg (2 sites) References 1. CMMC Palliative care: Pain and symptom control guidelines 2. CMMC Palliative Care Guidance on the Diamorphine Shortage.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationPAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationRenal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
More informationAnticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO
Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationRenal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life
Guidance for Anticipatory prescribing for patients in renal failure (egfr
More informationEnd of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
More informationAlgorithms for Symptom Management. In End of Life Care
Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationPalliative Care Out-of-hours. A resource pack for West Dorset. Contents:
Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More information[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose
More informationPalliative Care Impact Survey
September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the
More informationGUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter
More informationANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients
More informationEAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved
More informationPalliative care for heart failure patients. Susan Addie
Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves
More informationSyringe driver in Palliative Care
Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24
More informationPENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved
More informationCare of dying adults in the last days of life. Improving care at the very end of life.
Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationThe last days of life in hospital and at home
The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview
More informationWaterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)
Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF
More informationConservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
More informationDiamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30
If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work
More informationMND Just in Case kit Information for GPs
MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationEnd of Life Care. Dr Anne Garry Consultant in Palliative Medicine
End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by
More informationApproach to symptom control near the end-of-life
Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition
More informationGuidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)
Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:
More informationCoversheet for Network Site Specific Group Agreed Documentation
Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance
More informationPHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS
PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In
More informationBREATHLESSNESS MANAGEMENT
Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationPalliative care for patients with brain cancer
Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative
More informationTreating the symptoms of kidney failure
Treating the symptoms of kidney failure Information for patients, relatives and carers Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact:
More informationAnticipatory prescribing and end of life considerations. Dr Stephanie Lippett
Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to
More informationThe last days of life Linda Magann CNC Palliative Care St George Hospital I m not afraid of dying, I just don t want to be there when it happens Woody Allen Palliative Care is an approach that improves
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationCLINICAL GUIDELINES FOR END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES
CLINICAL GUIDELINES F END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES OPENING STATEMENT: Insert Facility Name is committed to providing effective end-of-life symptom management to all residents. Symptom
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationEnd of Life Care in Dementia. Sue Atkins Dignity in Care/Dementia/Learning Disabilities Clinical Nurse Specialist
End of Life Care in Dementia Sue Atkins Dignity in Care/Dementia/Learning Disabilities Clinical Nurse Specialist Objectives Understanding the decline in people with dementia To recognise when patients
More informationSYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven
Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationEnd Stage Liver Disease Regional Audit Casenote Survey
1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace
More informationUsing strong opiods for pain in palliative care
Using strong opiods for pain in palliative care What are strong opioids? They are strong medicines used to control pain when weaker painkillers have not been effective. (They can also sometimes be used
More informationPCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING
Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS
More informationSUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:
FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationSYRINGE DRIVER MEDICATIONS
SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil
More informationRegional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.
Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.
More informationALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug
COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER
More informationPrimary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other
Chart review date: / / Reviewer: Centre Name: Hospital Home RACF DOB: / / AGE: GENDER: Male Female Admission Date: / / Death Date: / / 1. DIAGNOSIS Primary Diagnosis YES NO ICD - Code Cancer Cognitive
More informationEssential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice
Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34
More informationDrug Administration Document for Babies, Children and Young People Requiring Symptom Management
Drug Administration Document for Babies, Children and Young People Requiring Symptom Management Patients Name: Address: GP: of Birth: NHS : Weight, Location & : Known Allergies: of Known Allergies: Allergy
More informationSpecialist Palliative Care Service Referral Criteria and Guidance
Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referrals These guidelines cover referrals for patients with progressive terminal illness, whether
More informationImplementing the recommendation on medication management and symptom control
Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationA Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza
A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza Background This guidance is intended ONLY for use in situations where health services are overwhelmed and
More informationRestlessness Emotional support Self care
Comfort Airway Restlessness Emotional support Self care MED 12412 9/12 City of Hope Department of Supportive Care Medicine 1500 Duarte Road Duarte, CA 91010 August 2012 The following are recommendations
More informationCommunity and Mental Health Services. Palliative Care. Criteria and
Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients
More informationTarget audience: The target audience for this guidance are: GPs Care home managers and nurses, District nurses, and Specialist Palliative Care teams.
Anticipatory medication guidance for the last days of life for frail older people being care for in care homes who do not have Specialist Palliative Care needs Purpose of guidance: The purpose of this
More informationThis survey aims to look at individual practice and can be completed by any healthcare professional.
This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)
More informationSpecialist Palliative Care Audit and Guidelines Group (SPAGG)
Specialist Palliative Care Audit and Guidelines Group (SPAGG) Clinical Guideline for the Prescribing and Administration of Furosemide via continuous subcutaneous infusion (CSCI) for Heart Failure Patients
More informationSyringe Drivers. Back to top
Page 1 of 8 Syringe Drivers Introduction Indications for use Advantages Method Siting syringe driver Boost facility Transfer to hospital/hospice syringe driver drugs Drug compatibility P.r.n medication
More informationManaging dying with chronic heart failure
Heart failure Managing dying with chronic heart failure Chronic heart failure (CHF) is predominantly a pathology of old age affecting 5% of those over 75 years of age. It is more common than cancer and
More informationStrong opioids for palliative care patients
Other formats Strong opioids for palliative care patients If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast, British Sign Language
More informationOpioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.
Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient
More informationManaging Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.
Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any
More informationManagement of acute asthma in children in emergency department. Moderate asthma
152 Moderate asthma SpO2 92% No clinical features of severe asthma NB: If a patient has signs and symptoms across categories, always treat according to their most severe features agonist 2-10 puffs via
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5
NHS...... Grampian Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults Co-ordinators: Consultant Anaesthetist, Lead Acute Pain
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery
Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery Co-ordinators: Dr Karen Cranfield, Consultant Anaesthetist, Lead Acute Pain Sector
More informationSpecialist Palliative Care Referral for Patients
Specialist Palliative Care Referral for Patients This guideline covers referrals for patients with progressive terminal illness, whether due to cancer or other disease. For many patients in the late stages
More informationGG&C Chronic Non Malignant Pain Opioid Prescribing Guideline
GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,
More informationThe Mid Yorkshire Macmillan Specialist Palliative Care Team
The Mid Yorkshire Macmillan Specialist Palliative Care Team Morphine and Strong Opioid information leaflet Information for patients/carers The mere mention of Morphine can be enough to conjure up all sorts
More informationPREOPERATIVE ANAEMIA PATHWAY
PREOPERATIVE ANAEMIA PATHWAY Surname: Unit No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: GP Name: GP Practice: Planned Operation: Postcode: Mobile
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationTraining in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts
Training in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts August 204 Produced by Dr Fiona Hicks onsultant in Palliative Medicine
More informationCONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259
Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor:
More informationNHS Grampian. Care Plan Palliative & Supportive. Acute Care Settings
NHS Grampian Palliative & Supportive Care Plan 2013 Acute Care Settings Contents Page 1. Introduction 2. Standards 3. The identification of the palliative patient 4. Assessment of the palliative patient
More informationTitle Protocol for the Management of Urinary Tract Infections for Adult Females and Children in MIUs and WICs
Document Control Title Protocol for the Management of Urinary Tract Infections for Adult Females and Children in MIUs and WICs Author Author s job title Professional Lead, Minor Injuries Unit Directorate,
More informationKetorolac injection. Supportive care
Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is
More informationLong Term Care Formulary HCD - 08
1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally
More informationInvitation and Family Questionnaire
Invitation and Family Questionnaire RELIEF, COMFORT AND SUPPORT: Palliative Approach Family Meeting Adapted from The University of Queensland The University of Queensland/ Blue Care Research and Practice
More informationManaging Care at End of Life:
Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has
More informationCare of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital
Care of the dying in End Stage Kidney Disease (ESKD) - Conservative Elizabeth Josland Renal Supportive Care CNC St George Hospital Introduction What does conservative management look like? How does the
More informationURN: Family name: Given name(s): Address: Initial Signature Print Name Role
Do Not Write in this binding margin v5.00-02/2012 Mat. No.: 10206019 SW030b The State of Queensland (Queensland Health) 2012 Contact CIM@health.qld.gov.au ÌSW030bIÎ Facility: s Never Replace Clinical Judgement
More informationUrinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition
Urinary Catheter Passport A guide to looking after a urinary catheter (for service users and healthcare workers) 2nd Edition Contact details Urinary Catheter Passport Service user Name Address Postcode
More informationHealthEd The Annual Women s Health Update 2016
Presentation overview Background End of life planning for the woman with cancer Palliative Care Framework of care based on prognostication Key processes within the framework to meet emergent clinical needs
More informationDrug Prescription and Administration Record
Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING
More information